In COVID-19 patients with acute respiratory distress syndrome (ARDS), measuring DBP levels may be especially important in determining 25OHD concentrations, because DBP is a negative acute-phase protein, with levels plummeting by nearly a third in patients with ARDS (5). This evidence concerns the gene DDAH2 and acute respiratory distress syndrome.